A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia

• Published in: Internal Medicine Vol. 56; no. 23; pp. 3127 - 3133
• Main Authors: Hojo, Mariko, Nagahara, Akihito, Asaoka, Daisuke, Shimada, Yuji, Sasaki, Hitoshi, Matsumoto, Kohei, Takeda, Tsutomu, Ueyama, Hiroya, Matsumoto, Kenshi, Watanabe, Sumio
• Format: Journal Article
• Language: English
• Published: Japan The Japanese Society of Internal Medicine 01.01.2017; Japan Science and Technology Agency
• Subjects: Antidepressants; Antidepressive Agents - therapeutic use; Clinical Trials as Topic; Dyspepsia; Dyspepsia - drug therapy; functional dyspepsia; Humans; Internal medicine; Male; Original; Pain; psychotropic agents; Psychotropic drugs; Psychotropic Drugs - therapeutic use; Reviews; Statistical analysis; Systematic review; psychotropic agents; functional dyspepsia
• ISSN: 0918-2918; 1349-7235; 1349-7235
• DOI: 10.2169/internalmedicine.9099-17

Objective Functional dyspepsia (FD) is defined as persistent or recurrent pain or discomfort centered in the upper abdomen without organic disease. Psychosocial factors have been proposed as an important element in the pathophysiology of FD. Therefore, psychotropic agents having antianxiety or antidepressive action are expected to alleviate FD. We previously reported on the treatment of FD using such agents in a systematic review, wherein the effectiveness of the agents on FD was suggested, although there were several limitations. We searched for articles on this subject after our systematic review and re-reviewed them systematically. Methods Articles were searched for in MEDLINE from 2003 to 2014 using terms related to antianxiety or antidepressive agents. Clinical studies in which the effectiveness of such agents was clearly stated were selected from the retrieved articles. The newly selected and previously selected studies were combined, and statistical analyses were carried out. Results Nine studies were selected. Five of the studies indicated a significant symptomatic improvement using psychotropic drugs. A statistical analysis suggested a significant treatment effect of psychotropic agents having antianxiety or antidepressive action [pooled relative risk (PRR), 0.72; 95% confidence interval (95% CI), 0.52-0.99; p=0.0406] but did not show a significant benefit of treatment with agents having an antidepressive action alone (PRR, 0.63; 95% CI, 0.38-1.03; p=0.0665). Conclusion Our systematic review suggested that psychotropic drugs having antianxiety and antidepressive actions as a whole might be effective in alleviating FD symptoms, whereas those having only antidepressive action were not effective.